Central Trust CO Biogen Inc. Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Central Trust CO holds 233 shares of BIIB stock, worth $40,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares

233

Previous 236 1.27%

Holding current value

$40,493

Previous $54,000 16.67%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$189.07 - $236.8 $567 - $710	-3 Reduced 1.27%	233 $45,000
Q2 2024 Aug 05, 2024	BUY	$190.52 - $236.72 $571 - $710	3 Added 1.29%	236 $54,000
Q3 2023 Oct 26, 2023	SELL	$253.3 - $285.89 $102,586 - $115,785	-405 Reduced 63.48%	233 $59,000
Q1 2023 Apr 19, 2023	BUY	$256.56 - $292.34 $62,857 - $71,623	245 Added 62.34%	638 $177,000
Q4 2022 Jan 26, 2023	SELL	$252.44 - $306.72 $50,488 - $61,344	-200 Reduced 33.73%	393 $0
Q3 2022 Nov 17, 2022	SELL	$194.69 - $268.46 $4,867 - $6,711	-25 Reduced 4.05%	593 $158,000
Q1 2022 May 03, 2022	SELL	$193.77 - $244.14 $3,875 - $4,882	-20 Reduced 3.13%	618 $130,000
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $39,186 - $50,359	-175 Reduced 21.53%	638 $153,000
Q3 2021 Oct 19, 2021	SELL	$282.99 - $369.05 $7,357 - $9,595	-26 Reduced 3.1%	813 $230,000
Q2 2021 Jul 23, 2021	SELL	$259.0 - $414.71 $28,490 - $45,618	-110 Reduced 11.59%	839 $290,000
Q1 2021 Apr 23, 2021	BUY	$242.95 - $284.63 $26,724 - $31,309	110 Added 13.11%	949 $265,000
Q3 2020 Oct 22, 2020	BUY	$264.77 - $305.71 $3,706 - $4,279	14 Added 1.7%	839 $238,000
Q2 2020 Jul 14, 2020	SELL	$258.66 - $342.55 $11,639 - $15,414	-45 Reduced 5.17%	825 $220,000
Q1 2020 Apr 17, 2020	SELL	$268.85 - $341.04 $1,344 - $1,705	-5 Reduced 0.57%	870 $275,000
Q3 2019 Oct 28, 2019	SELL	$217.44 - $243.88 $119,374 - $133,890	-549 Reduced 38.55%	875 $204,000
Q2 2019 Jul 12, 2019	SELL	$219.29 - $241.72 $653,484 - $720,325	-2,980 Reduced 67.67%	1,424 $0
Q1 2019 Apr 26, 2019	SELL	$216.71 - $338.96 $32,289 - $50,505	-149 Reduced 3.27%	4,404 $0
Q4 2018 Jan 08, 2019	BUY	$278.5 - $352.75 $41,775 - $52,912	150 Added 3.41%	4,553 $1.37 Million
Q3 2018 Oct 04, 2018	BUY	$293.51 - $383.83 $1,467 - $1,919	5 Added 0.11%	4,403 $0
Q2 2018 Jul 09, 2018	SELL	$257.52 - $306.91 $40,430 - $48,184	-157 Reduced 3.45%	4,398 $0
Q1 2018 Apr 04, 2018	BUY	$260.13 - $367.91 $8,324 - $11,773	32 Added 0.71%	4,555 $0
Q4 2017 Jan 23, 2018	BUY	$307.64 - $344.58 $35,686 - $39,971	116 Added 2.63%	4,523 $0
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $1.24 Million - $1.45 Million	4,407	4,407 $0

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account